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Testing for Myocardial Ischemia
The End of Surrogates?*
Matthias G. Friedrich, MD
Calgary, Alberta, Canada. . . they knew infinitely much—but was it valuable
to know all of this, not knowing that one and only
thing, the most important thing, the solely important
thing?
—Hermann Hesse (1)
Rationale for Imaging Ischemia
Diagnosis and appropriate management of coronary
artery disease is one of the most important clinical
tasks in Western society. The high incidence of this
disease and its impact on quality of life, survival, and
health care costs render it the highest priority. In this
context, except for patients with acute coronary syn-
See page 375
drome, myocardial ischemia testing has to be con-
sidered the single-most—if not the only—relevant
tool for deciding whether or not to revascularize (2).
The hemodynamic relevance of coronary artery
stenosis and its impact on ischemia are altered by a
multitude of confounders (Fig. 1), which limit the
utility of coronary angiography and other tests.
Consistently, quantitative coronary angiography,
albeit a reasonable approach at first glance, has been
proven insufficient for discriminating relevant from
irrelevant stenosis when compared with the patho-
physiologic marker trans-stenotic fractional flow
reserve (3,4). Accordingly, its role for clinical deci-
sion making has been questioned (5).
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Stephenson Cardiovascular MR Centre at the Libin Cardio-
vascular Institute of Alberta, Departments of Cardiac Sciences and
Radiology, University of Calgary, Calgary, Alberta, Canada.With the improved efficacy of medical treatment,
interventional or surgical treatment of coronary
artery stenosis is more and more considered not
useful in patients without significant myocardial
ischemia, even in the presence of significant coro-
nary artery stenosis (6).
Limitations of Existing Diagnostic Approaches
Although numerous diagnostic approaches are avail-
able, current diagnostic tools for assessing myocardial
ischemia, however, have a severe limitation in com-
mon: They are just plain surrogates. Markers are
derived from stress tests using electrocardiography,
nuclear medicine techniques, or cardiac magnetic res-
onance (CMR), with stress being imposed either
physically or pharmacologically. Alternatively, vasodi-
lators such as adenosine are administered to induce
hyperemia, with regionally delayed or lacking inflow
serving as a marker for perfusion deficits. All these
markers, however, do not allow a view beyond inflow
characteristics and therefore cannot account for other
factors affecting the balance of oxygen demand and
supply. Neither repolarization changes nor inhomo-
geneous tracer uptake or contrast material distribution
are myocardial ischemia. The best available marker
appears to be trans-stenotic fractional flow reserve (7).
But even this approach is flawed, mainly by its invasive
nature and its relative insensitivity to account for
collateral blood flow (8). The truth, the real target for
diagnosis and therapy, lies behind anatomy and flow:
tissue oxygenation. Unfortunately, we do not have the
clinical tools to get there. CMR is about to change
that forever.
Oxygenation-Sensitive CMR for Assessing
Myocardial Ischemia
First developed for brain studies by Ogawa et al.
(9), a technique known as blood oxygen level–
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386ependent magnetic resonance imaging allows for
enerating images in which the signal intensity is
usceptible to changes of hemoglobin oxygenation.
Earlier experimental data have indicated a strong
orrelation between CMR and tissue oxygenation
10) and also showed that the method is not suscep-
ible to changes of blood flow and blood volume (11).
nitial patient studies confirmed the potential for
linical application (12,13), but were limited by incon-
istent image quality and susceptibility to artifacts.
ore recent CMR techniques have shown significant
mprovement in image quality (14).
The study by Jahnke et al. (15) published in this
ssue of iJACC provides important clinical evidence
or the potential of oxygenation-sensitive CMR. In
0 patients with suspected or known coronary artery
isease, the authors applied oxygenation-sensitive
MR at baseline and during adenosine infusion
nd compared results with those acquired by a
tandard first-pass perfusion CMR protocol during
he same session and with quantitative coronary
ngiography. Using the latter as the standard of
ruth, they found that oxygenation-sensitive CMR,
lbeit not as well as first-pass perfusion CMR,
redicted coronary artery stenoses of 50%.
The study design suffers from using quantitative
oronary angiography as their reference, which has
imitations for validating a method that directly as-
esses myocardial ischemia. Otherwise, however, the
tudy design is straightforward. The CMR method-
logy, a navigator-guided T2-prepared segmented
C
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Figure 1. Confounders of Tests for Myocardial Ischemia
In vivo modiﬁers of coronary blood ﬂow and tissue oxygenation, w
stenosis and blood ﬂow. LV  left ventricular.radient echo sequence, is established for this ap- aroach, although the acquisition time may vary sig-
ificantly between subjects. Oxygenation-sensitive
MR at higher field strength (3.0-T, as used in this
tudy) has an approximately 4-fold higher sensitivity
o detect changes of myocardial oxygenation when
ompared with 1.5-T, making it the preferred ap-
roach for future clinical studies.
The results are consistent with very recent vali-
ation studies with positron emission tomography
s a standard of truth in animals (16) and humans
17). Of note, in this study, the authors apparently
ncountered a consistently high image quality and a
igh contrast-to-noise ratio. Both were inconsistent
n some previous studies.
urrent Perspective
he study underscores the growing scope of CMR
s the most versatile diagnostic tool in cardiovascu-
ar medicine and its unique value for the noninva-
ive assessment of the myocardium.
Oxygen-sensitive CMR is still in the steep part of
he learning curve, and a widespread clinical applica-
ion will require fine-tuned simplified protocols and
valuation tools. Clinical studies will have to scrutinize
ts utility in various clinical scenarios, such as sus-
ected microvascular dysfunction and acute cardiac
isease. The method will have to be integrated in
omprehensive CMR protocols without significantly
rolonging scan times. There should, however, be
ittle doubt that, for the first time in assessing coronary
nary
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